Experts introduce the 2026 AACE type 2 diabetes algorithm’s new classification pathway and frame misclassification—especially of adult-onset type 1 diabetes—as a central problem the update is designed to address.
Back
Beyond Type 2: Classifying Diabetes and Screening for Hypercortisolism in the 2026 AACE Algorithm
Today we’re focusing on what may be the single biggest conceptual addition to this update — a brand-new diabetes classification algorithm that pushes clinicians to look beyond a default diagnosis of type 2.
Beyond Type 2: Classifying Diabetes and Screening for Hypercortisolism in the 2026 AACE Algorithm
Episodes
All
All
Experts review standard diagnostic criteria for diabetes, then detail phenotypic and clinical features that support—but do not definitively confirm—a diagnosis of type 2 diabetes, emphasizing the limitations of BMI-based assumptions.
Spot hidden type 1/LADA in overweight adults: learn key red flags, and how autoantibodies plus C-peptide guide accurate diagnosis.
Learn key clues that diabetes isn’t type 2, and how autoantibody tests plus C‑peptide guide accurate adult type 1/LADA diagnosis.
Explore signs of uncommon diabetes—from pancreatic disease and MODY to steroid, transplant, and checkpoint-inhibitor autoimmune causes.
Learn how clinicians spot uncommon diabetes causes—from pancreatic disease and MODY to steroids, transplants, and checkpoint inhibitors—before treatment.
Advertisement
Advertisement
Trending on HCPLive
1
Combination Therapy, Adherence, and Access: A PAH Expert Roundtable
2
Allergists Debate Newer Nonsteroidal Topicals for Atopic Dermatitis
3
CaRi-Heart Receives FDA De Novo Authorization for Coronary Inflammation
4
Ritlecitinib Improves Repigmentation in Nonsegmental Vitiligo Phase 3 Data
5